Antisynthetase syndrome synonyms

Antisynthetase syndrome is a rare autoimmune condition primarily characterized by the presence of anti-tRNA synthetase antibodies, most notably anti-Jo-1. While it is most commonly referred to as antisynthetase syndrome, it is sometimes historically or clinically categorized under the broader umbrella of idiopathic inflammatory myopathies or overlap syndromes.

What are the common synonyms and clinical names for Antisynthetase syndrome?

In medical literature and clinical records, you may encounter several terms for antisynthetase syndrome, though none are as precise as the current standard name. Historically, because the condition presents as a combination of features seen in other diseases, it was often described as an "overlap syndrome." Some older or less common labels include:

• Anti-Jo-1 syndrome: Named after the most common antibody associated with the condition.


• Jo-1 syndrome: A shorthand often used by clinicians, though it is technically imprecise as other antibodies (like PL-7, PL-12, EJ, and OJ) can also cause the condition.


• Synthetase syndrome: A simplified version sometimes found in research papers.


• Inflammatory myopathy with interstitial lung disease: A descriptive phrase often used in clinical notes to highlight the two most critical organ systems involved.

Why does Antisynthetase syndrome have multiple names?

The naming of antisynthetase syndrome has evolved alongside our understanding of immunology. In the past, patients presenting with muscle inflammation (myositis) and lung scarring (interstitial lung disease) were often diagnosed with dermatomyositis or polymyositis. As researchers identified specific autoantibodies directed against aminoacyl-tRNA synthetases—the enzymes responsible for protein synthesis—it became clear that these patients shared a distinct clinical profile. Consequently, the medical community moved toward the term antisynthetase syndrome to reflect this specific underlying biological mechanism rather than just the outward symptoms.

How is the condition classified in medical databases?

Standardized medical classification systems are essential for ensuring consistency in patient care. In major databases, antisynthetase syndrome is categorized as follows:

• Orphanet: Recognized as ORPHA:98357, listed under the umbrella of inflammatory myopathies.


• OMIM (Online Mendelian Inheritance in Man): While it does not have a single dedicated "gene" entry, it is frequently cross-referenced within entries for idiopathic inflammatory myopathies.


• ICD-10/ICD-11: There is no single specific code for antisynthetase syndrome; it is typically coded under M33.2 (polymyositis) or M33.9 (dermatopolymyositis, unspecified), reflecting its historical classification.

Which name should patients and doctors use?

The term antisynthetase syndrome is the preferred nomenclature used by rheumatologists and pulmonologists worldwide. Using this specific term in your medical records helps doctors recognize the high risk of interstitial lung disease, which is a hallmark of this condition. At DiseaseMaps.org, we have seen 36 people with antisynthetase syndrome join our community, and we encourage patients to use the standardized name to ensure they receive care tailored to the specific pulmonary and musculoskeletal manifestations of this syndrome.

Next steps

• Consult a board-certified rheumatologist to ensure your records are accurately labeled for insurance and clinical management.


• Request a full myositis-specific antibody panel if your diagnosis is currently listed only as "polymyositis."


• Connect with the 36 members of the DiseaseMaps community to share experiences on managing symptoms like Raynaud’s phenomenon and lung involvement.


• Stay informed by monitoring updates from the Myositis Association or the NIH GARD database.

Medical disclaimer: This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment; always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.

References

• Orphanet: Rare Disease Database (ORPHA:98357).


• NIH Genetic and Rare Diseases Information Center (GARD): Antisynthetase Syndrome overview.


• The Myositis Association: Clinical guidelines for inflammatory myopathies.


• PubMed: "Antisynthetase syndrome: a review of the clinical, serological, and therapeutic aspects."